Compare NVO & NFLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVO | NFLX |
|---|---|---|
| Founded | 1923 | 1997 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Consumer Electronics/Video Chains |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.4B | 308.7B |
| IPO Year | 2001 | 2000 |
| Metric | NVO | NFLX |
|---|---|---|
| Price | $46.71 | $79.35 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 34 |
| Target Price | $51.00 | ★ $119.23 |
| AVG Volume (30 Days) | 9.7M | ★ 23.8M |
| Earning Date | 05-06-2026 | 04-16-2026 |
| Dividend Yield | ★ 3.19% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.03 |
| Revenue | N/A | ★ $45,183,036,000.00 |
| Revenue This Year | N/A | $15.99 |
| Revenue Next Year | $3.70 | $11.74 |
| P/E Ratio | ★ $13.60 | $40.65 |
| Revenue Growth | N/A | ★ 15.85 |
| 52 Week Low | $35.12 | $65.08 |
| 52 Week High | $64.16 | $1,267.00 |
| Indicator | NVO | NFLX |
|---|---|---|
| Relative Strength Index (RSI) | 52.05 | 62.95 |
| Support Level | $43.25 | $81.93 |
| Resistance Level | $48.23 | $83.56 |
| Average True Range (ATR) | 0.98 | 2.15 |
| MACD | 0.07 | 0.23 |
| Stochastic Oscillator | 63.82 | 86.66 |
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Netflix's relatively simple business model involves only one business, its streaming service. It has the biggest television entertainment subscriber base in both the United States and the collective international market, with more than 300 million subscribers globally. Netflix has exposure to nearly the entire global population outside of China. The firm has traditionally avoided a regular slate of live programming or sports content, instead focusing on on-demand access to episodic television, movies, and documentaries. The firm introduced ad-supported subscription plans in 2022, giving the firm exposure to the advertising market in addition to the subscription fees that have historically accounted for nearly all its revenue.